Search Results

Puracol® Plus Ag MicroScaffold™ Wound Dressing is indicated for the management of:

• Full thickness and partial thickness wounds
• Pressure ulcers
• Venous ulcers
• Ulcers caused by mixed vascular etiologies
• Diabetic ulcers
• First and second degree burns
• Donor sites and other bleeding surface wounds
• Abrasions
• Trauma wounds healing by secondary intention
• Dehisced wounds
• Surgical wounds
• Dehisced surgical wounds

These dressings may be cut to size and may be layered for the management of deep wounds.

Not Found

I am sorry, but the provided text does not contain the information required to answer your request. The document is an FDA 510(k) clearance letter for a wound dressing, which grants market approval by deeming the device substantially equivalent to a predicate device. It specifies indications for use, precautions, and contraindications.

However, it does not provide any details about:

• Acceptance criteria and reported device performance (in terms of specific metrics like sensitivity, specificity, accuracy, etc.)
• Details of a study proving the device meets acceptance criteria.
• Sample sizes for test or training sets.
• Data provenance, number or qualifications of experts, or adjudication methods for ground truth.
• Whether MRMC or standalone comparative effectiveness studies were performed, or any associated effect sizes.
• How ground truth was established for training or test sets.

Essentially, this document is a regulatory approval notice, not a detailed scientific study report on device performance.

Ask a specific question about this device